UNH Stock Soars as UnitedHealth Delivers Strong Q2 Earnings Beat

UnitedHealth Group's (UNH) stock is on a hot streak after delivering an impressive Q2 earnings beat and raising its 2026 outlook. The company posted $6.38 EPS on $112.03 billion revenue, exceeding estimates by 31%.

The strong performance has Wall Street analysts bullish on UNH's future prospects. Goldman Sachs and UBS raised their price targets to $490, implying a 15% upside, while Morgan Stanley lifted its target to $529, suggesting a 24% gain.

Truist, Oppenheimer, and KeyBanc also increased their targets to $500 each, indicating over 20% potential growth. UnitedHealth's CEO Stephen Hemsley said the company is 'returning to form' as stronger performance disciplines take hold.